Company code: 302726732
UAB "Froceth"
Contact the company (B2B)
Biotech, biochemical, and pharmaceutical industry
  • Biotechnology
  • Biopharmacy

We are the first and only biotechnology company in Lithuania manufacturing advanced therapy medicinal products (ATMPs) individually for each patient. We develop our products using patients’ own tissues and cells in the manufacturing process, and by addressing the specific needs of each person in field of: oncoimmunology, traumatology, auto-immune diseases and cosmetology. In addition to that we provide tissue bank services and contract manufacturing solutions.

Current export markets:
Export turnover: 20%
  • Czech Republic
  • Germany
  • Latvia
  • Slovakia
  • Thailand
  • 0.5M-1M Turnover, €
  • 10-49 Employees
  • 2014Year of establishment
manufacturing advanced therapy medicinal products (ATMPs), contracting manufacturing for clinical trials and ATMP R&D projects

SVF (stromal vascular fraction) cell product Dendritic cell vaccine T-cell product CIK (Cytokine-induced killer cells)

  • GMP sertificate (iATMP),
  • Permission to produce dendritic cell activated with oncolysate (DLP)
  • License for Tissue banking (stromal vascular fraction)
  • License for dendritic cell activated with oncolysate (DLP)
  • License for the Cytokine Induced Killer cell preparation (CIK)
  • License for the T – Cell Vacination (TCV)
  • License for the Proprietary Stromal Vascular Fraction (SVFP)
  • ISO 9001
  • ISO 13845
  • GMP (Good Manufacturing Practice)